ProPhase Labs Inc PRPH 深 滬
等待開盤 10-01 09:30:00 美东时间
0.4578
+0.020
+4.57%
華盛通- 最 高0.468
- 今 開0.4365
- 成交量 105.45万股
- 最 低 0.4315
- 昨 收 0.4378
- 總市值 1901.76万
- 52周最高 2.4999
- 市盈率 靜 --
- 換手率 2.54%
- 52周最低 0.2179
- 委 比 -99.75%
- 總股本 4154.12万
- 歷史最高 15.25
- 量 比 0.93
- 振 幅 8.34%
- 歷史最低 -1.87
- 每 手 1
- 風險率 0.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE
ProPhase Labs, Inc. announced that its three COVID-19 testing laboratory subsidiaries filed for Chapter 11 bankruptcy reorganization in New Jersey, seeking to recover tens of millions of dollars owed by insurance companies. This action aims to streamline collections and restore financial stability, with potential net collections of $50 million or more. The parent company and its other initiatives, including the development of a life-saving esopha...
09-23 12:00
ProPhase Continues its Exploration of a Crypto Treasury Strategy
ProPhase Labs announced an agreement for potential advisory services and is exploring investment opportunities in digital assets, specifically a crypto treasury strategy to enhance shareholder value. CEO Ted Karkus emphasized the company's underlying value, canceling its ELOC due to no interest in discounted financing. ProPhase aims to update shareholders on its Crown Medical Collections initiative, potentially generating $50 million, and progres...
09-22 12:00
ProPhase Labs Shareholders Approve Strategic Expansion, Including Increase In Authorized Shares To 1B
ProPhase Labs Stockholders Deliver Strong Mandate at Special MeetingUNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next generation biotech, genomics
09-12 20:12
ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
ProPhase Labs shareholders overwhelmingly approved all proposals at the September 9 special meeting, with over 75% support for each item. This included authorization to increase the company's authorized shares to 1 billion, enabling strategic initiatives like a potential crypto treasury strategy and growth of its subsidiaries. The meeting follows the re-election of the board in June with over 90% support. CEO Ted Karkus emphasized the mandate all...
09-12 12:00
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 80.7% to $1.35 during Tues...
09-10 01:06
ProPhase Labs Inc. to Participate in Renmark’s Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025
ProPhase Labs Inc. will participate in Renmark Financial Communications' virtual non-deal roadshow on September 4, 2025, to discuss its investor presentation, which includes updates on its crypto treasury strategy, potential liquidity events, and the cancellation of the Equity Line of Credit (ELOC). Investors can register for the live event or access the replay post-event via the provided link. The event will feature Ted Karkus, the company's Cha...
09-03 12:00
Prophase Labs Ends Stock Purchase Agreement with Keystone
Prophase Labs ( ($PRPH) ) has issued an update. On August 27, 2025, ProPhase La...
08-28 18:47
ProPhase Labs Q2 EPS $(0.11) Beats $(0.15) Estimate, Sales $1.247M May Not Be Comparable To $3.550M Estimate
The Company did not generate any revenues from diagnostic services for the three months ended June 30, 2025 and 2024, respectively.
08-13 20:04
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Earnings Preview For ProPhase Labs
ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report...
08-13 04:02
